Morgan Stanley issued buy ratings and price targets on Viking Therapeutics stock on May 27, 2026, with Truist Financial also involved.
6 reports, 1 independent
Updated Aug 6
Gone quiet
- Reports
- 6
- Developments
- 1
- Repetition
- 83%
New informationRepeats or wire copies
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Morgan Stanley issued buy ratings and price targets on Viking Therapeutics stock on May 27, 2026, with Truist Financial also involved.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
-
Viking Therapeutics
company in San Diego, United States
Nothing else this week.